Raised S.B. No. 202
Session Year 2024
 


AN ACT CONCERNING THE DEPARTMENT OF CONSUMER PROTECTION'S RECOMMENDATIONS REGARDING PRESCRIPTION DRUG CONTROL.

To: (1) Allow a licensed manufacturer or wholesaler to sell a hypodermic needle or syringe to an advanced practice registered nurse, optometrist or physician assistant; (2) redefine "commissioner", "pharmaceutical manufacturer" and "pharmaceutical marketing firm" for the purposes of various statutes concerning pharmaceutical marketing; (3) eliminate a requirement that the Department of Consumer Protection annually analyze certain information submitted to the department concerning pharmaceutical marketing; (4) extend the date by which the department is required to submit an annual report concerning pharmaceutical marketing; (5) eliminate an overlapping prohibition concerning automatic reciprocal discipline of pharmacists; (6) modify the actions the Commissioner of Consumer Protection may take following a violation of certain statutes concerning pharmaceutical marketing; (7) require certain practitioners that dispense, administer or prescribe controlled substances to make certain records available to the department; and (8) make minor, technical and conforming changes to various statutes concerning prescription drug control.

Introduced by:
General Law Committee

 New today  2-4 days old  5 days & older
   Text of Bill
 Raised Bill  [doc]
  View or Add Notes to SB-202

Add Notes to SB-202

Go To My Bills


This bill is in My Bills.
Do you wish to go to My Bills?

Co-sponsors for Amendment LCO:

Bill History

 Date Action Taken
 2/23/2024Public Hearing 02/27
 2/22/2024Referred to Joint Committee on General Law

NOTE: Please direct all inquiries regarding the status of bills to the Office of the House Clerk and/or Senate Clerks' Office.